Gray matter pathology in (chronic) MS: Modern views on an early observation

Involvement of the gray matter (GM) in the pathology of multiple sclerosis (MS) was already recognized in the early days of MS research, but the detection of (cortical) GM lesions under the microscope and with magnetic resonance imaging (MRI) techniques was initially suboptimal and could only recently be enhanced. The visualization of GM lesions in vivo opens new doors for studies focusing on clinical, especially cognitive, effects of GM pathology, as well as for monitoring of neuroprotective treatment. However, so far little is known about what causes GM pathology. In this review, several pathogenetic mechanisms will be discussed, affecting the MS brain both from the 'outside-in' and from the 'inside-out'. Also, the use and reliability of MRI atrophy measures as a monitoring tool for GM damage in the therapeutic setting will be reviewed.

[1]  M. Morganti-Kossmann,et al.  Neurotransmitters in cerebrospinal fluid reflect pathological activity , 1997, European journal of clinical investigation.

[2]  J. Geurts,et al.  Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. , 2003, Brain : a journal of neurology.

[3]  P. Narayana,et al.  Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging , 2007, American Journal of Neuroradiology.

[4]  D. Arnold,et al.  Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis , 2006, Neurology.

[5]  D. Hinton,et al.  Viral Induced Demyelination , 2001, Brain pathology.

[6]  Frederik Barkhof,et al.  Extensive Hippocampal Demyelination in Multiple Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[7]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[8]  A J Thompson,et al.  Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[10]  H. Lassmann,et al.  Cortical Demyelination Can Be Modeled in Specific Rat Models of Autoimmune Encephalomyelitis and Is Major Histocompatability Complex (MHC) Haplotype-Related , 2006, Journal of neuropathology and experimental neurology.

[11]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[12]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[13]  R. Fujinami,et al.  Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination , 2002, Springer Seminars in Immunopathology.

[14]  A J Thompson,et al.  Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis , 2003, Multiple sclerosis.

[15]  Rohit Bakshi,et al.  Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis , 2007, NeuroImage.

[16]  M. Filippi,et al.  Evidence for enhanced functional activity of cervical cord in relapsing multiple sclerosis , 2008, Magnetic resonance in medicine.

[17]  Jia Newcombe,et al.  Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[19]  F. Barkhof,et al.  Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. , 2006, Radiology.

[20]  Marco Rovaris,et al.  Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI , 2005, NeuroImage.

[21]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[22]  M Cercignani,et al.  Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[23]  H. D. de Vries,et al.  The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions , 2007, Journal of neuropathology and experimental neurology.

[24]  David H. Miller,et al.  Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis. , 2007, Archives of neurology.

[25]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[26]  A. Thompson,et al.  Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR , 2000, Multiple sclerosis.

[27]  Paul M. Matthews,et al.  Diffuse cortical atrophy in a marmoset model of multiple sclerosis , 2008, Neuroscience Letters.

[28]  E. Aronica,et al.  Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions , 2005, Journal of Neuroimmunology.

[29]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[30]  L. Bö,et al.  The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.

[31]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[32]  Stephen Smith,et al.  Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. , 2003, Brain : a journal of neurology.

[33]  A J Thompson,et al.  Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis , 2007, Multiple sclerosis.

[34]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[35]  J. Hodges,et al.  Cognitive presentation of multiple sclerosis: evidence for a cortical variant , 2003, Journal of neurology, neurosurgery, and psychiatry.

[36]  A. Minagar,et al.  HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. , 2007, International review of neurobiology.

[37]  B. Ransom,et al.  Excitotoxic Mechanisms of Ischemic Injury in Myelinated White Matter , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[39]  F. Barkhof,et al.  Altered diffusion tensor in multiple sclerosis normal‐appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration , 2006, Journal of magnetic resonance imaging : JMRI.

[40]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[41]  S. van Buuren,et al.  Selective association of multiple sclerosis with infectious mononucleosis , 2008, Multiple sclerosis.

[42]  M Riva,et al.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. , 2006, AJNR. American journal of neuroradiology.

[43]  J. Rosenbluth,et al.  Central myelin in the mouse mutant shiverer , 1980, The Journal of comparative neurology.

[44]  Rohit Bakshi,et al.  Regional lobar atrophy predicts memory impairment in multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.

[45]  D. Hanley,et al.  Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.

[46]  Stephen M. Rao,et al.  Neuropsychology of multiple sclerosis. , 1995, Current opinion in neurology.

[47]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.

[48]  Paul M Matthews,et al.  Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. , 2006, Brain : a journal of neurology.

[49]  M. Pender,et al.  Immunology of multiple sclerosis , 2007, Current allergy and asthma reports.

[50]  N. Lobaugh,et al.  Structural brain abnormalities in multiple sclerosis patients with major depression , 2004, Neurology.

[51]  A. Jackson,et al.  Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images. , 1999, AJNR. American journal of neuroradiology.

[52]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.

[53]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[54]  V. Carelli,et al.  Myelin, mitochondria, and autoimmunity , 2008, Neurology.

[55]  A. J. Thompson,et al.  Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability , 2007, NeuroImage.

[56]  F. H. Garrison,et al.  Garrison's History of Neurology , 1969 .

[57]  M. Filippi,et al.  Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis , 2008, Neurology.

[58]  F Barkhof,et al.  Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging , 2009, Multiple sclerosis.

[59]  F. Barkhof.  The clinico‐radiological paradox in multiple sclerosis revisited , 2002, Current opinion in neurology.

[60]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[61]  David H. Miller,et al.  Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.

[62]  M Rovaris,et al.  Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[63]  S. Amor,et al.  Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments , 2008, Neurobiology of Disease.

[64]  Hans Lassmann,et al.  Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.

[65]  Frederik Barkhof,et al.  In vivo MR imaging of hippocampal lesions in multiple sclerosis , 2008, Journal of magnetic resonance imaging : JMRI.

[66]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[67]  J. Geurts.  Is progressive multiple sclerosis a gray matter disease? , 2008, Annals of neurology.

[68]  R. Gonsette.  Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? , 2008, Multiple sclerosis.

[69]  Marco Rovaris,et al.  Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. , 2005, Archives of neurology.

[70]  Daniel Pelletier,et al.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.

[71]  Hans Lassmann,et al.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions , 2002, Journal of the Neurological Sciences.

[72]  D. Louis Collins,et al.  Relating neocortical pathology to disability progression in multiple sclerosis using MRI , 2004, NeuroImage.

[73]  R. Rudick,et al.  Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions , 2008, Annals of neurology.

[74]  Domenico Caputo,et al.  Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis , 2008, NeuroImage.

[75]  Hans-Jochen Heinze,et al.  Sailer, M. et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126, 1734-1744 , 2003 .

[76]  W. Kamphorst,et al.  Hypothalamic Lesions in Multiple Sclerosis , 2001, Journal of neuropathology and experimental neurology.

[77]  P Kapeller,et al.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[78]  P M Matthews,et al.  Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. , 2000, Brain : a journal of neurology.

[79]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[80]  M. Zarei.  Clinical characteristics of cortical multiple sclerosis , 2006, Journal of the Neurological Sciences.

[81]  L. Bö,et al.  Homogeneity of active demyelinating lesions in established multiple sclerosis , 2008, Annals of neurology.

[82]  Frederik Barkhof,et al.  MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis , 2006, Magnetic resonance in medicine.

[83]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[84]  Giuseppe Scotti,et al.  Functional cortical changes in patients with multiple sclerosis and nonspecific findings on conventional magnetic resonance imaging scans of the brain , 2003, NeuroImage.

[85]  Bertrand Audoin,et al.  Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of multiple sclerosis , 2003, Human brain mapping.

[86]  A. Kangarlu,et al.  Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. , 2007, AJNR. American journal of neuroradiology.

[87]  Klaus-Armin Nave,et al.  Axon-glial signaling and the glial support of axon function. , 2008, Annual review of neuroscience.

[88]  M. Calabrese,et al.  Extensive cortical inflammation is associated with epilepsy in multiple sclerosis , 2008, Journal of Neurology.

[89]  P M Matthews,et al.  The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis , 2000, Annals of neurology.

[90]  B. '. ’t Hart,et al.  Immunization With Neurofilament Light Protein Induces Spastic Paresis and Axonal Degeneration in Biozzi ABH Mice , 2007, Journal of neuropathology and experimental neurology.

[91]  B. Trapp,et al.  Depolarization-Induced Ca2+ Release in Ischemic Spinal Cord White Matter Involves L-type Ca2+ Channel Activation of Ryanodine Receptors , 2003, Neuron.

[92]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[93]  D. Pitt,et al.  Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage , 2001, Annals of neurology.

[94]  P. Stys.  Axonal degeneration in multiple sclerosis: Is it time for neuroprotective strategies? , 2004, Annals of neurology.

[95]  R. Zivadinov,et al.  I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy , 2007, Multiple sclerosis.

[96]  R. Rudick,et al.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.

[97]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[98]  James Lowe,et al.  Spinal Cord Gray Matter Demyelination in Multiple Sclerosis—A Novel Pattern of Residual Plaque Morphology , 2006, Brain pathology.

[99]  B. Trapp,et al.  Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors , 2009, Annals of neurology.

[100]  D. Pham‐Dinh,et al.  Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice , 2002, Journal of Neuroimmunology.

[101]  F. Barkhof,et al.  Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? , 2008, Journal of Neurology.

[102]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[103]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[104]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[105]  D. Pham‐Dinh,et al.  Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice , 2005, European journal of immunology.

[106]  Yasuzo Tsukada,et al.  Fine structure of the central myelin sheath in the myelin deficient mutant Shiverer mouse, with special reference to the pattern of myelin formation by oligodendroglia , 1981, Brain Research.

[107]  Frank L Mastaglia,et al.  Hypothalamic lesions in multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[108]  J. Newcombe,et al.  Glutamate Receptor Expression in Multiple Sclerosis Lesions , 2008, Brain pathology.

[109]  J. De Keyser,et al.  Seizures in multiple sclerosis , 2008, Epilepsia.

[110]  H. Wekerle,et al.  Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice1 , 2001, The Journal of Immunology.

[111]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[112]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[113]  G. Giovannoni,et al.  Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis — are we there yet? , 2007, Multiple sclerosis.

[114]  J. L. Cox,et al.  Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[115]  A. Pérez-Samartín,et al.  Excitotoxic damage to white matter , 2007, Journal of anatomy.

[116]  M. Ramanathan,et al.  Epstein–Barr virus is associated with grey matter atrophy in multiple sclerosis , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[117]  M. Filippi,et al.  Correlations between Structural CNS Damage and Functional MRI Changes in Primary Progressive MS , 2002, NeuroImage.